Edwards Lifesciences (EW) Asset Utilization Ratio (2010 - 2026)

Edwards Lifesciences' Asset Utilization Ratio history runs 17 years deep, the most recent figure standing at 0.47 for Q1 2026.

• On a quarterly basis, Asset Utilization Ratio rose 10.17% year-over-year to 0.47 in Q1 2026; TTM through Mar 2026 was 0.47, a 10.17% increase from a year earlier, with the FY2025 full-year figure at 0.45, down 6.52% from the prior year.
• Asset Utilization Ratio rose to 0.47 in Q1 2026 per EW's latest filing, from 0.45 in the prior quarter.
• Across five years, Asset Utilization Ratio topped out at 0.64 in Q2 2022 and bottomed at 0.42 in Q4 2024.
• The 5-year median for Asset Utilization Ratio is 0.48 (2023), against an average of 0.5.
• Across the five-year window, Asset Utilization Ratio slipped 27.74% in 2023 and climbed 10.17% in 2026, its largest moves.
• Year by year, Asset Utilization Ratio stood at 0.53 in 2022, then climbed by 1.43% to 0.53 in 2023, then decreased by 21.85% to 0.42 in 2024, then advanced by 7.65% to 0.45 in 2025, then gained by 3.7% to 0.47 in 2026.
• Per Business Quant, the three latest EW Asset Utilization Ratio figures stand at 0.47 (Q1 2026), 0.45 (Q4 2025), and 0.44 (Q3 2025).